These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 6306322

  • 1. Immunohistology of malignant rabbit fibroma virus--a comparative study with rabbit myxoma virus.
    Strayer DS, Sell S.
    J Natl Cancer Inst; 1983 Jul; 71(1):105-16. PubMed ID: 6306322
    [Abstract] [Full Text] [Related]

  • 2. Malignant rabbit fibroma virus: observations on the culture and histopathologic characteristics of a new virus-induced rabbit tumor.
    Strayer DS, Cabirac G, Sell S, Leibowitz JL.
    J Natl Cancer Inst; 1983 Jul; 71(1):91-104. PubMed ID: 6306326
    [Abstract] [Full Text] [Related]

  • 3. Malignant rabbit fibroma virus causes secondary immunosuppression in rabbits.
    Strayer DS, Skaletsky E, Cabirac GF, Sharp PA, Corbeil LB, Sell S, Leibowitz JL.
    J Immunol; 1983 Jan; 130(1):399-404. PubMed ID: 6292305
    [Abstract] [Full Text] [Related]

  • 4. Leporine acquired immune deficiency disease.
    Sell S, Strayer D, Skaletsky E, Corbeil L, Cabirac G, Leibowitz J.
    Symp Fundam Cancer Res; 1986 Jan; 38():97-111. PubMed ID: 3018882
    [Abstract] [Full Text] [Related]

  • 5. Immunologic dysfunction during viral oncogenesis. I. Nonspecific immunosuppression caused by malignant rabbit fibroma virus.
    Strayer DS, Sell S, Skaletsky E, Leibowitz JL.
    J Immunol; 1983 Nov; 131(5):2595-600. PubMed ID: 6195270
    [Abstract] [Full Text] [Related]

  • 6. Immunity to pasteurellosis in compromised rabbits.
    Corbeil LB, Strayer DS, Skaletsky E, Wunderlich A, Sell S.
    Am J Vet Res; 1983 May; 44(5):845-50. PubMed ID: 6307088
    [Abstract] [Full Text] [Related]

  • 7. Reversal of virus-induced immune suppression.
    Strayer DS, Leibowitz JL.
    J Immunol; 1986 Apr 01; 136(7):2649-53. PubMed ID: 3005416
    [Abstract] [Full Text] [Related]

  • 8. An immunohistologic study of Shope fibroma virus in rabbits: tumor rejection by cellular reaction in adults and progressive systemic reticuloendothelial infection in neonates.
    Sell S, Scott CB.
    J Natl Cancer Inst; 1981 Feb 01; 66(2):363-73. PubMed ID: 6256578
    [Abstract] [Full Text] [Related]

  • 9. Virus-induced loss of class I MHC antigens from the surface of cells infected with myxoma virus and malignant rabbit fibroma virus.
    Boshkov LK, Macen JL, McFadden G.
    J Immunol; 1992 Feb 01; 148(3):881-7. PubMed ID: 1309843
    [Abstract] [Full Text] [Related]

  • 10. Molecular analysis of immunosuppression induced by virus replication in lymphocytes.
    Heard HK, O'Connor K, Strayer DS.
    J Immunol; 1990 May 15; 144(10):3992-9. PubMed ID: 2159037
    [Abstract] [Full Text] [Related]

  • 11. Immune and non-immune macrophage resistance to the fibroma-myxoma virus complex.
    Tompkins WA, Rama Rao GV, Woan MC.
    J Reticuloendothel Soc; 1975 Jul 15; 18(1):23-33. PubMed ID: 168379
    [No Abstract] [Full Text] [Related]

  • 12. Immunologic dysfunction during viral oncogenesis. II. Inhibition of cellular immunity to viral antigens by malignant rabbit fibroma virus.
    Skaletsky E, Sharp PA, Sell S, Strayer DS.
    Cell Immunol; 1984 Jun 15; 86(1):64-74. PubMed ID: 6327086
    [Abstract] [Full Text] [Related]

  • 13. Transforming growth factor alpha, Shope fibroma growth factor, and vaccinia growth factor can replace myxoma growth factor in the induction of myxomatosis in rabbits.
    Opgenorth A, Nation N, Graham K, McFadden G.
    Virology; 1993 Feb 15; 192(2):701-9. PubMed ID: 8380671
    [Abstract] [Full Text] [Related]

  • 14. Immunosuppression in viral oncogenesis. III. Effects of virus infection on interleukin 1 and interleukin 2 generation and responsiveness.
    Strayer DS, Horowitz M, Leibowitz JL.
    J Immunol; 1986 Dec 01; 137(11):3632-8. PubMed ID: 3023485
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of virus replication does not alter malignant rabbit fibroma virus-induced immunosuppression.
    Strayer DS, Skaletsky E, Leibowitz JL.
    Clin Exp Immunol; 1986 Oct 01; 66(1):25-36. PubMed ID: 3026700
    [Abstract] [Full Text] [Related]

  • 16. Immunosuppression during viral oncogenesis. V. Resistance to virus-induced immunosuppressive factor.
    Strayer DS, Dombrowski J.
    J Immunol; 1988 Jul 01; 141(1):347-51. PubMed ID: 2837511
    [Abstract] [Full Text] [Related]

  • 17. Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes.
    Macen JL, Graham KA, Lee SF, Schreiber M, Boshkov LK, McFadden G.
    Virology; 1996 Apr 01; 218(1):232-7. PubMed ID: 8615027
    [Abstract] [Full Text] [Related]

  • 18. Immunosuppression during viral oncogenesis. IV. Generation of soluble virus-induced immunologic suppressor molecules.
    Strayer DS, Korber K, Dombrowski J.
    J Immunol; 1988 Mar 15; 140(6):2051-9. PubMed ID: 2831278
    [Abstract] [Full Text] [Related]

  • 19. Growth of malignant rabbit fibroma virus in lymphoid cells.
    Strayer DS, Skaletsky E, Leibowitz JL, Dombrowski J.
    Virology; 1987 May 15; 158(1):147-57. PubMed ID: 3033886
    [Abstract] [Full Text] [Related]

  • 20. Limitations of plasmid vaccines to complex viruses: selected myxoma virus antigens as DNA vaccines were not protective.
    Adams MM, van Leeuwen BH, Kerr PJ.
    Vaccine; 2004 Nov 25; 23(2):198-204. PubMed ID: 15531037
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.